Outlook Therapeutics Inc (OTLK)

[thermo]

My understanding is we should see something around the end of this month +/-. There's a decent change we get a Priority Review, which will signal FDA's view of the importance of Lytenava.

I'm thinking about investing more money. My preferred approach is a direct negotiated investment (I'm not in talks now and, if I was, I couldn't mention it). We're in a bear market, so attractive terms are a requirement, but we'll see what happens.